34.52
Harmony Biosciences Holdings Inc stock is traded at $34.52, with a volume of 770.45K.
It is down -2.95% in the last 24 hours and up +7.25% over the past month.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
See More
Previous Close:
$35.54
Open:
$34.23
24h Volume:
770.45K
Relative Volume:
1.17
Market Cap:
$1.99B
Revenue:
$681.88M
Net Income/Loss:
$122.63M
P/E Ratio:
16.36
EPS:
2.11
Net Cash Flow:
$220.18M
1W Performance:
-2.70%
1M Performance:
+7.25%
6M Performance:
-12.37%
1Y Performance:
+11.55%
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Name
Harmony Biosciences Holdings Inc
Sector
Industry
Phone
(484) 539-9800
Address
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
HRMY
Harmony Biosciences Holdings Inc
|
34.59 | 1.98B | 681.88M | 122.63M | 220.18M | 2.11 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
381.25 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
570.96 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
418.24 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
681.17 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
309.95 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-21-25 | Initiated | Truist | Buy |
Jul-10-25 | Resumed | Goldman | Neutral |
Jun-02-25 | Resumed | Oppenheimer | Outperform |
Feb-11-25 | Initiated | Deutsche Bank | Buy |
Dec-17-24 | Initiated | H.C. Wainwright | Buy |
Oct-10-24 | Resumed | Raymond James | Outperform |
Sep-10-24 | Initiated | UBS | Buy |
Jun-21-24 | Initiated | Citigroup | Buy |
Jan-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
Sep-25-23 | Downgrade | Goldman | Neutral → Sell |
Sep-07-23 | Initiated | Berenberg | Buy |
Apr-20-23 | Initiated | BofA Securities | Neutral |
Oct-14-22 | Upgrade | Janney | Neutral → Buy |
Oct-14-22 | Upgrade | Jefferies | Hold → Buy |
Aug-03-22 | Downgrade | Jefferies | Buy → Hold |
Jul-13-22 | Downgrade | Goldman | Buy → Neutral |
Jul-07-22 | Initiated | Mizuho | Buy |
Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
Dec-01-21 | Initiated | Oppenheimer | Outperform |
Nov-04-21 | Initiated | Raymond James | Outperform |
Sep-23-21 | Initiated | Needham | Buy |
Mar-29-21 | Upgrade | Goldman | Neutral → Buy |
Sep-14-20 | Initiated | Goldman | Neutral |
Sep-14-20 | Initiated | Jefferies | Buy |
Sep-14-20 | Initiated | Piper Sandler | Overweight |
View All
Harmony Biosciences Holdings Inc Stock (HRMY) Latest News
Harmony Biosciences falls as Q2 revenue misses estimates despite profit beat - Investing.com Nigeria
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates - Yahoo Finance
Harmony Biosciences Holdings, Inc. SEC 10-Q Report - TradingView
Harmony Biosciences Q2 2025 slides: revenue up 16% as WAKIX nears blockbuster status - Investing.com
Topline Data from the Phase 3 registrational trial of ZYN002 in Fragile X syndrome on track for Q3 2025. - Placera.se
Harmony Biosciences : HRMY Q2 2025 Earnings Presentation FINAL - MarketScreener
Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025 | HRMY Stock - GuruFocus
Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025 - Yahoo Finance
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory - Insider Monkey
Harmony Biosciences Holdings Inc. Stages Intraday Comeback — Trend ChangeSecure Portfolio Growth Plan Review - beatles.ru
Harmony Biosciences Holdings Inc (HRMY) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Published on: 2025-08-04 07:58:17 - metal.it
Is Harmony Biosciences Holdings Inc. stock overvalued or undervaluedMaximize gains with proven stock analysis - Jammu Links News
What are analysts’ price targets for Harmony Biosciences Holdings Inc. in the next 12 monthsAchieve consistent double-digit returns - Jammu Links News
Why is Harmony Biosciences Holdings Inc. stock attracting strong analyst attentionUnlock your trading potential with expert tips - Jammu Links News
What catalysts could drive Harmony Biosciences Holdings Inc. stock higher in 2025 - Jammu Links News
Harmony Biosciences Holdings Inc. Stock Analysis and ForecastTriple-digit returns - Jammu Links News
What is the dividend policy of Harmony Biosciences Holdings Inc. stockAchieve rapid portfolio growth with expert help - Jammu Links News
What makes Harmony Biosciences Holdings Inc. stock price move sharplyGrow your wealth steadily and securely - Jammu Links News
When is Harmony Biosciences Holdings Inc. stock expected to show significant growthRapid capital growth - Jammu Links News
What are the latest earnings results for Harmony Biosciences Holdings Inc.Phenomenal trading returns - Jammu Links News
Should I hold or sell Harmony Biosciences Holdings Inc. stock in 2025Invest smarter with real-time trading signals - Jammu Links News
Harmony Biosciences to Release Q2 2025 Financial Results on August 5, 2025, Before Market Open - AInvest
Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - simplywall.st
Can Harmony Biosciences Holdings Inc. Regain Momentum After BreakdownRisk Managed Intraday Trade Alerts Increase in Volume - beatles.ru
Published on: 2025-07-31 00:25:32 - metal.it
Harmony Biosciences to Announce Q2 2025 Financial Results on August 5 - MSN
Published on: 2025-07-30 03:51:38 - metal.it
Published on: 2025-07-30 00:07:05 - metal.it
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Why Harmony Biosciences Holdings Inc. stock attracts strong analyst attentionReal Time Stock Movement Analysis Indicates Breakout - metal.it
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Immunocore Holdings (IMCR) and Harmony Biosciences Holdings (HRMY) - The Globe and Mail
Are Bears Losing Grip on Harmony Biosciences Holdings Inc.Alpha Focused Technical Trade Signals Gain Attention - metal.it
Harmony Biosciences Holdings Inc. May Be Forming Higher Low — Chartwatchers AlertRisk Controlled Picks With Real Returns Outlined - metal.it
Published on: 2025-07-29 03:50:34 - metal.it
What are the technical indicators suggesting about Harmony Biosciences Holdings Inc.Capitalize on market momentum for profits - jammulinksnews.com
Harmony Biosciences Holdings Inc. Earnings Report Breakdown: What Investors Should KnowInsider Level Guidance - metal.it
Published on: 2025-07-28 01:23:24 - jammulinksnews.com
Are Strong Financial Prospects The Force That Is Driving The Momentum In Harmony Biosciences Holdings, Inc.'s NASDAQ:HRMY) Stock? - 富途牛牛
What analysts say about Harmony Biosciences Holdings Inc. stockFree Stock Index Interpretation - PrintWeekIndia
What drives Harmony Biosciences Holdings Inc. stock priceOutstanding growth strategies - Autocar Professional
Is Harmony Biosciences Holdings Inc. a good long term investmentSkyrocketing investment returns - Autocar Professional
How high can Harmony Biosciences Holdings Inc. stock price go in 2025Free Stock Market Query - Jammu Links News
Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025 - MarketScreener
Most Volatile Stocks in the US (July 2025) - Investing.com
Harmony Biosciences Holdings Inc Stock (HRMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):